Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 9/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | F7 | P08709 | 5/20 | 0.40 |
| ▸ | F9 | P00740 | 3/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | F11 | P03951 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6890249 | 0.86 | F10 (0.49) | F10NPC1 | |
| Trifluoroacetic Acid SCHEMBL6775993 | 0.86 | F10 (0.42) | F10NPC1 | |
| Trifluoroacetic Acid SCHEMBL6770182 | 0.85 | NPC1 (0.42) | F10NPC1 | |
| Trifluoroacetic Acid SCHEMBL6765882 | 0.84 | F10 (0.56) | F10NPC1 | |
| Trifluoroacetic Acid SCHEMBL6770318 | 0.84 | TRPV1 (0.42) | F10NPC1 | |
| Trifluoroacetic Acid SCHEMBL6775790 | 0.82 | F10 (0.41) | F10NPC1 | |
| Trifluoroacetic Acid SCHEMBL6775232 | 0.82 | RAD52 (0.42) | F10F7NPC1 | |
| Trifluoroacetic Acid SCHEMBL6771022 | 0.82 | F10 (0.40) | F10F7F9F11PRSS1 | |
| Trifluoroacetic Acid SCHEMBL6769129 | 0.82 | F10 (0.53) | F10 | |
| Trifluoroacetic Acid SCHEMBL6771145 | 0.80 | ROCK1 (0.48) | F10F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825181-B1 | ORALLY ADMINISTRATED TO EXHIBIT A STRONG ANTICOAGULANT EFFECT BY INHIBITING ACTIVATED BLOOD- COAGULATION FACTOR X | AJINOMOTO CO., INC. (JP) | 2004-11-30 | — | — | US | disclosed |
| EP-1065200-A1 | AMINOISOQUINOLINE DERIVATIVES | Ajinomoto Co., Inc. (JP) | 2001-01-03 | — | — | EP | disclosed |